title: Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase.
abstract: The CTL response to HIV-1 is more vigorous than for any known human pathogen and may be a significant factor in preventing the progression to symptomatic disease. T cell lines, generated by non-specific stimulation with PHA and IL-2, may be reproducibly used to identify HIV-1 isolate-invariant epitopes recognized by the CTL of infected individuals. The CTL response in each of 12 infected individuals to envelope and reverse transcriptase (RT) is dominated by the recognition of one or two viral isolate-invariant epitopes. Seven subjects respond to a single gp160 epitope; three subjects recognize 2 gp160 epitopes. There is a significant increase in recognition of epitopes in the C terminal 104 amino acids of gp41 (p less than 0.002); in fact 40% of the subjects that respond to gp160 recognize the C terminal 20-mer. The CTL-mediated lysis of gp160-expressing targets is MHC restricted, but not all individuals that share the same serologically defined class I-restricting element respond to the same epitope. Recognition of the terminal 20mer is restricted by both A30 and B8. The response to RT in six subjects is distributed over the RT protein. The six subjects recognize four separate regions defined by truncated RT-vaccinia recombinants, but none of the subjects' CTL demonstrate significant recognition of the RT epitope identified in H-2k mice and some humans.
authors.affiliation: Department of Medicine, New England Medical Center, Boston, MA.
authors.forename: J
authors.initials: J
authors.lastname: Lieberman
authors.forename: J A
authors.initials: JA
authors.lastname: Fabry
authors.forename: M C
authors.initials: MC
authors.lastname: Kuo
authors.forename: P
authors.initials: P
authors.lastname: Earl
authors.forename: B
authors.initials: B
authors.lastname: Moss
authors.forename: P R
authors.initials: PR
authors.lastname: Skolnik
mesh_terms: D000595:Amino Acid Sequence; D002460:Cell Line; D002874:Chromosome Mapping; D003602:Cytotoxicity, Immunologic; D015686:Gene Products, env / Q000276:immunology*; D005822:Genetic Vectors; D019302:HIV Envelope Protein gp160; D015658:HIV Infections / Q000276:immunology*; D054303:HIV Reverse Transcriptase; D006679:HIV Seropositivity / Q000276:immunology*; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D016056:Immunodominant Epitopes / Q000235:genetics* / Q000276:immunology*; D016130:Immunophenotyping; D008969:Molecular Sequence Data; D011498:Protein Precursors / Q000276:immunology*; D012194:RNA-Directed DNA Polymerase / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D015686:Gene Products, env; D019302:HIV Envelope Protein gp160; D006680:HLA Antigens; D016056:Immunodominant Epitopes; D011498:Protein Precursors; D054303:HIV Reverse Transcriptase; D012194:RNA-Directed DNA Polymerase